FoRx Therapeutics
Luca Iacovino has work experience in the field of biochemistry and X-ray crystallography. Luca started working as a Scientist at FoRx Therapeutics in December 2020. Prior to this, Luca worked as a PHD Graduate Student at IUSS - Scuola Universitaria Superiore Pavia starting from October 2017. Luca also gained experience as a Research Fellow at Università degli Studi di Pavia from December 2016 to October 2017.
Luca Iacovino earned a Master's degree in Medicinal Chemistry from Sapienza Università di Roma, which they attended from 2011 to 2016. Following that, they pursued a PhD in Structural Biology and Biotechnology at Istituto Universitario di Studi Superiori, Pavia, where they studied from 2016 to 2020.
FoRx Therapeutics
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.